Helen of Troy Limited - Common Stock (HELE)

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.

Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.

Helen of Troy stock plunged 25% after a steep Q1 earnings miss and weak Q2 outlook, driven largely by tariff-related pressures.

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

U.S. stock futures declined on Thursday after ending higher on Wednesday. Futures of major benchmark indices were trading lower.

Canaccord cut its price target on Helen of Troy to $47 from $53 and maintains ‘Buy’ rating as lower earnings are expected from higher tariff products flowing through the profit and loss statement in the near term.

In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.

Helen of Troy reported a Q4 sales decline of 0.7% year-on-year to $485.89 million, beating the analyst consensus estimate of $482.67 million.

Numerous public companies have updated their 2025 guidance in response to the Trump administration's tariffs on China, Mexico and Canada, but additional tariffs on other countries could have significant impacts.

Helen of Troy reported a 3.4% year-on-year decline in Q3 FY25 sales,. The decline in sales was mainly attributed to weaker performance in the Beauty & Wellness segment, which saw a 9.3% drop.